#5USNYSEMid-cap

ANF

Abercrombie & Fitch

$143.54USD

Data as of 2026-09-05

Composite Score75.6Exceptional

Margin of safety+4%Fair value

Fair value$148.80

Target$235.16

Loss chance26%Moderate-low

SizeMid cap

SectorConsumer Discretionary

Dividend—

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Consumer Discretionary median (n=194)

Quality
Profit margins & asset efficiency
88
Exceptional
Consumer Discretionary median (n=194) 47
Value
Price vs fundamentals
70
Exceptional
Consumer Discretionary median (n=194) 51
Growth
Revenue & earnings trajectory
81
Exceptional
Consumer Discretionary median (n=194) 49
Momentum
Recent price strength
75
Exceptional
Consumer Discretionary median (n=194) 44
Health
Balance sheet & solvency
57
Strong
Consumer Discretionary median (n=194) 44
Profitability
ROE, ROA, ROIC
84
Exceptional
Consumer Discretionary median (n=194) 51
Technical
Trend & volatility signals
70
Exceptional
Consumer Discretionary median (n=194) 45
Risk
Volatility & drawdown profile
44
Average
Consumer Discretionary median (n=194) 37

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Fair price check

6 different valuation methods each estimate what ANF should be worth, then we compare to today's price.

Near fair value

Models suggest ANF is priced roughly in line

Today's price

$143.54

Median fair price

$148.80

+4% vs today's price

Of 6 methods:2 say cheap2 say fair2 say pricey

EV/EBITDAUndervalued
thinks it's a bargain — estimates $235.16, about 64% above today
P/E multiplesUndervalued
thinks it's a bargain — estimates $187.15, about 30% above today
P/B multiplesFair
thinks it's fairly priced — estimates $155.57, about 8% above today
DCF (2-stage)Fair
thinks it's fairly priced — estimates $142.02, about 1% below today
Residual IncomeOvervalued
thinks it's expensive — estimates $93.85, about 35% below today
Graham (defensive)Overvalued
thinks it's expensive — estimates $80.57, about 44% below today

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $148.80
Margin of safety(vs fair value): +3.5%
Max (ex-outliers): $235.16
Tangible BVPS: $31.63

Cross-source price disagreement

Median of all applicable methods (current price $143.54). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$6.09B
Revenue (TTM)	$5.34B
Net income (TTM)	$543.53M
Operating cash flow (TTM)	$819.65M
CapEx (TTM)	$253.19M
Free cash flow (TTM)CFO − CapEx	$566.46M
Total assets	$3.59B
Total liabilities	N/A
Stockholders' equity	$1.35B
Cash & equivalents	$627.72M
Shares outstanding	42.43M
EPS (basic)	$12.81
EPS (diluted)	$12.81
P/E ratio (TTM)	11.21

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-09-04
Latest period end: 2026-08-28
Filing lag: 1 days
Missing metrics: 6(total_liabilities, gross_profit, research_and_development, dividends_paid, accounts_receivable, goodwill)